Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1373229 | Bioorganic & Medicinal Chemistry Letters | 2007 | 4 Pages |
Abstract
A series of four bicyclic cores were prepared and evaluated as cyclin-dependent kinase-2 (CDK2) inhibitors. From the in-vitro and cell-based analysis, the pyrazolo[1,5-a]pyrimidine core (represented by 9) emerged as the superior core for further elaboration in the identification of novel CDK2 inhibitors.
Graphical abstractPyrazolo[1,5-a]pyrimidine 9 emerged as a key template for further optimization toward the identification of CDK inhibitors.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Michael P. Dwyer, Kamil Paruch, Carmen Alvarez, Ronald J. Doll, Kerry Keertikar, Jose Duca, Thierry O. Fischmann, Alan Hruza, Vincent Madison, Emma Lees, David Parry, Wolfgang Seghezzi, Nicole Sgambellone, Frances Shanahan, Derek Wiswell,